Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma

Clinical Endocrinology

Volumn 64, Issue 6, 2006, Pages 703-710

  Donckier, Julian E ^a   Michel, Luc ^a   Delos, Monique ^a   Havaux, Xavier ^b   Van Beneden, Ronald ^c  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c University Hospital of Mont Godinne ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; EUTHYROIDISM; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; MALE; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID CARCINOMA; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; ANGIOPOIETIN-1; ANGIOPOIETIN-2; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; ENDOTHELIN-1; FEMALE; HASHIMOTO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RECEPTOR, TIE-2; RNA, MESSENGER; THYROID NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33646850587     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02535.x     Document Type: Article

References (35)

1. Donckier, J., Hanet, C., Berbinschi, A., Galanti, L., Robert, A., Van Mechelen, H., Pouleur, H. Ketelslegers, J.M. 1991 Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation, 84, 2476 2484.
2. Palmer, R.M., Ferrige, A.G. Moncada, S. 1987 Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 524 526.
3. Donckier, J., Michel, L., Van Beneden, R., Delos, M. Havaux, X. 2003 Increased expression of endothelin-1 and its mitogenic receptor ETA in human papillary thyroid carcinoma. Clinical Endocrinology, 59, 354 360.
4. Van Beneden, R., Michel, L., Havaux, X., Delos, M. Donckier, J. 2004 Increased expression of endothelin-1 converting enzyme in human thyroid carcinoma. Clinical Endocrinology, 60, 146 147.
5. Donckier, J., Michel, L., Delos, M., Van Beneden, R. Havaux, X. 2004 Endothelin axis expression in medullary thyroid carcinoma: a potential therapeutic target. Clinical Endocrinology, 61, 280 284.
6. Nelson, J., Bagnato, A., Battistini, B. Nisen, P. 2003 The endothelin axis: emerging role in cancer. Nature Review, 3, 110 116.
7. Wink, D.A. Mitchell, J.B. 2003 Nitric oxide and cancer: an introduction. Free Radical Biology and Medicine, 34, 951 954.
8. Thomsen, L.L., Lawton, F.G., Knowles, R.G., Beesley, J.E., Riveros-Moreno, V. Moncada, S. 1994 Nitric oxide synthase activity in human gynecological cancer. Cancer Research, 54, 1352 1354.
9. Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrown, L.G., Knowles, R.G. Moncada, S. 1995 Nitric oxide synthase activity in human breast cancer. British Journal of Cancer, 72, 41 44.
10. Nathan, C. 1997 Inducible nitric oxide synthase: what difference does it make? Journal of Clinical Investigation, 15, 2417 2423.
11. Xu, W., Liu, L.Z., Loizidou, M., Ahmed, M. Charles, I.G. 2002 The role of nitric oxide in cancer. Cell Research, 12, 311 320.
12. Xie, K. Huang, S. 2003 Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency. Free Radical Biology and Medicine, 34, 969 986.
13. Nose, F., Ichikawa, T., Fujiwara, M. Okayasu, I. 2002 Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase. American Journal of Clinical Pathology, 117, 546 551.
14. Patel, A., Fenton, C., Terrell, R., Powers, P.A., Dinauer, C., Tuttle, R.M. Francis, G.L. 2002 Nitrotyrosine inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents. Journal of Endocrinological Investigation, 25, 675 683.
15. Salani, D., Di Castro, V., Nicrotra, M.R., Rosano, L., Tecce, R., Venuti, A., Natali, P.G. Bagnato, A. 2000 Role of endothelin-1 in neovascularisation of ovarian carcinoma. American Journal of Pathology, 157, 1537 1547.
16. Spinella, F., Rosano, L., Di Castro, V., Natali, P.G. Bagnato, A. 2002 Endothelin-1 induces vascular endothelial growth factor by increasing hypoxia-inducible factor-1α in ovarian carcinoma cells. Journal of Biological Chemistry, 277, 27850 27855.
17. Wulfing, P., Kersting, C., Tio, J., Fischer, R.J., Wulfing, C., Poremba, C., Diallo, R., Bocker, W. Kiesel, L. 2004 Endothelin-1, endothelin-A- and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clinical Cancer Research, 10, 2393 2400.
18. Jenkins, D.C., Charles, I.G., Thomsen, L.L., Moss, D.W., Holmes, L.S., Baylis, S.A., Rhodes, P., Westmore, K., Emson, P.C. Moncada, S. 1995 Roles of nitric oxide in tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 92, 4392 4396.
19. Fam, N.P., Verma, S., Kutryk, M. Stewart, D.J. 2003 Clinician guide to angiogenesis. Circulation, 108, 2613 2618.
20. Visconti, R.P., Richardson, C.D. Sato, T.N. 2002 Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proceedings of the National Academy of Sciences of the United States of America, 99, 8219 8224.
21. Reveneau, S., Arnould, L., Jolimoy, G., Hilpert, S., Lejeune, P., Saint-Giorgo, V., Belichard, C. Jeannin, J.F. 1999 Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate and expression of progesterone receptors. Laboratory Investigation, 79, 1215 1225.
22. Vakkala, M., Kahlos, K., Lakari, E., Paakko, P., Kinnula, V. Soini, Y. 2000 Inducible nitric oxide synthase expression, apoptosis and angiogenesis in in situ invasive breast carcinomas. Clinical Cancer Research, 6, 2408 2416.
23. Jaiswal, M., Larusso, N.F. Gores, G.J. 2001 Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. American Journal of Physiology. Gastrointestinal and Liver Physiology, 281, 6626 6634.
24. Klotz, T., Bloch, W., Volberg, C., Engelmann, U. Addicks, K. 1998 Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer, 82, 1897 1903.
25. Doi, K., Akaike, T., Horie, H., Noguchi, Y., Fujii, S., Beppu, T., Ogawa, M. Maeda, H. 1996 Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer, 77, 1598 1604.
26. Suzuki, S., Kajikuri, J., Suzuki, A. Itoh, T. 1991 Effects of endothelin-1 on endothelial cells in the porcine coronary artery. Circulation Research, 69, 1361 1368.
27. Boulanger, C. Luscher, T.F. 1990 Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. Journal of Clinical Investigation, 85, 587 590.
28. McMillen, M.A. Sumpio, B.E. 1995 Endothelins: polyfunctional cytokines. Journal of the American College of Surgeons, 80, 621 637.
29. Turner, H.E., Harris, A.L., Melmed, S. Wass, J.A.H. 2003 Angiogenesis in endocrine tumors. Endocrine Reviews, 24, 600 632.
30. Klein, M., Picard, E., Vignaud, J.M., Marie, B., Bresler, L., Toussaint, B., Weryha, G., Duprez, A. Leclere, J. 1999 Vascular endothelial growth factor gene and protein: strong expression in thyroiditis and thyroid carcinoma. Journal of Endocrinology, 161, 41 49.
31. Bunone, G., Vigneri, P., Mariani, L., Buto, S., Collini, P., Pilotti, S., Pierotti, M.A. Bongarzone, I. 1999 Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. American Journal of Pathology, 155, 1967 1976.
32. Wang, J.F., Milosveski, V., Schramek, C., Fong, G.H., Becks, G.P. Hill, D.J. 1998 Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function. Journal of Endocrinology, 157, 5 12.
33. Vidal, S., Lloyd, R.V., Moya, L., Scheithauer, B.W. Kovacs, K. 2002 Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary. Journal of Histochemistry and Cytochemistry, 50, 533 540.
34. Boocock, C.A., Charnock-Jones, D.S., Sharkey, A.M., Mclaren, J., Barker, P.J., Wright, K.A., Twentyman, P.R. Smith, S.K. 1995 Expression of vascular endothelial growth factor and its receptors flt-1 and KDR in ovarian carcinoma. Journal of the National Cancer Institute, 87, 506 516.
35. Babaei, S., Teichert-Kuliszewska, K., Zhang, Q., Jones, N., Dumont, D.J. Stewart, D.J. 2003 Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. American Journal of Pathology, 162, 1927 1936.